Investors
Newsroom
Careers
- Job Openings

Areas of Focus
Our Medicines
Pipeline
Science & Innovation
Patients & Caregivers
About
- Leadership Team
- Corporate Governance

Investors
Newsroom
Careers
- Job Openings

Lab technicians examining samples

Lab technicians examining samples

Latest News and Events

Home /

Newsroom

Now Approved

FDA Approval of Plozasiran to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Filter by

Year Published
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011

Selections

July 9, 2020

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis

Read More

July 8, 2020

Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Third Quarter Results

Read More

May 28, 2020

Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences

Read More

May 7, 2020

Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results

Read More

May 1, 2020

Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences

Read More

May 1, 2020

Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given

Read More

April 22, 2020

Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Second Quarter Results

Read More

April 10, 2020

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis

Read More

March 17, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Read More

March 17, 2020

Arrowhead Pharmaceuticals Announces Precautionary Measures to Mitigate Effects of Novel Coronavirus (COVID-19) Spread

Read More

1...22 23 24 25 26...58

Continue to Site

Footer Navigation

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
Careers

Facebook
Instagram
LinkedIn
Twitter

Privacy Policy
Cookie Policy
Terms of Use
Sitemap
Contact Us
Safety Reporting

© 2025 Arrowhead Pharmaceuticals, Inc.